Belief BioMed Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
270
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$120M
- Investors
-
7
Belief BioMed General Information
Description
Developer of gene therapy drugs designed for rare genetic and chronic diseases. The company's technology utilizes engineered aav capsids with tissue targeting and low immunogenicity, providing patients with treatment options for rare genetic and chronic conditions.
Contact Information
Website
www.beliefbiomed.comCorporate Office
- Block K, 5th Floor
- Number 780 Cailun Road, China Pilot Free Trade Zone
- Shanghai
- China
Corporate Office
- Block K, 5th Floor
- Number 780 Cailun Road, China Pilot Free Trade Zone
- Shanghai
- China
Belief BioMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 01-Mar-2022 | $120M | Completed | Generating Revenue | ||
| 5. Early Stage VC | 01-Aug-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 01-Dec-2020 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 28-May-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 21-Apr-2020 | $40M | $50.9M | Completed | Generating Revenue | |
| 1. Seed Round | 19-Jun-2018 | $10.9M | $10.9M | Completed | Startup |
Belief BioMed Patents
Belief BioMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022222869-A1 | Recombinant adeno-associated virus and application thereof | Inactive | 19-Apr-2021 | ||
| AU-2020258972-A1 | A new type of enzyme composition | Active | 19-Apr-2019 | ||
| AU-2020258972-B2 | A new type of enzyme composition | Active | 19-Apr-2019 | ||
| CA-3136853-A1 | A new type of enzyme composition | Pending | 19-Apr-2019 | ||
| EP-3956440-A1 | A new type of enzyme composition | Pending | 19-Apr-2019 | C12N9/0071 |
Belief BioMed Signals
Belief BioMed Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDG Capital | Growth/Expansion | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority | ||
| MPC (Beijing) | Venture Capital | Minority | ||
| Cenova Capital | Venture Capital | Minority | ||
| Qiming Venture Partners | Venture Capital | Minority |
Belief BioMed FAQs
-
When was Belief BioMed founded?
Belief BioMed was founded in 2018.
-
Where is Belief BioMed headquartered?
Belief BioMed is headquartered in Shanghai, China.
-
What is the size of Belief BioMed?
Belief BioMed has 270 total employees.
-
What industry is Belief BioMed in?
Belief BioMed’s primary industry is Drug Discovery.
-
Is Belief BioMed a private or public company?
Belief BioMed is a Private company.
-
What is the current valuation of Belief BioMed?
The current valuation of Belief BioMed is .
-
What is Belief BioMed’s current revenue?
The current revenue for Belief BioMed is .
-
How much funding has Belief BioMed raised over time?
Belief BioMed has raised $271M.
-
Who are Belief BioMed’s investors?
CDG Capital, LAV (Lilly Asia Fund), MPC (Beijing), Cenova Capital, and Qiming Venture Partners are 5 of 7 investors who have invested in Belief BioMed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process